Cargando…
Intrinsic Differences in Immune Checkpoint Inhibitor-Induced Myocarditis: A Retrospective Analysis of Real World Data
Immune-related myocarditis is a severe and even life-threatening immune-related adverse event (irAE) which may also be underestimated due to the challenge in diagnosis. The inherent difference between individuals with immune-associated myocarditis has received little attention. Our study aimed to id...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294234/ https://www.ncbi.nlm.nih.gov/pubmed/35865949 http://dx.doi.org/10.3389/fphar.2022.914928 |
_version_ | 1784749804885114880 |
---|---|
author | Lei, Yanna Zheng, Xiufeng Huang, Qian Li, Xiaoying Qiu, Meng Liu, Ming |
author_facet | Lei, Yanna Zheng, Xiufeng Huang, Qian Li, Xiaoying Qiu, Meng Liu, Ming |
author_sort | Lei, Yanna |
collection | PubMed |
description | Immune-related myocarditis is a severe and even life-threatening immune-related adverse event (irAE) which may also be underestimated due to the challenge in diagnosis. The inherent difference between individuals with immune-associated myocarditis has received little attention. Our study aimed to identify which baseline characteristics could contribute to distinguishing mild from severe ICI myocarditis. A retrospective analysis was conducted between March 2019 and June 2020 in West China Hospital, and 18 patients with immune-related myocarditis were studied. Patients were classified as having mild (n = 12) or severe myocarditis (n = 6), according to the clinical manifestations and hemodynamic complications. Factors associated with severe myocarditis were identified by comparing covariates derived from medical records in various groups. In this retrospective analysis, the median age of the 18 patients was 60 years old. Most myocarditis cases occur early and approximately after the first or second ICI infusion. The severity of myocarditis may be correlated with lactate dehydrogenase (LDH) (p = 0.04) and troponin levels (p = 0.0057). The relationship between troponin and myocarditis was further confirmed in another cohort, which included 30 patients. In addition, patients are more likely to develop multi-irAEs, and myositis was the most common second irAE. Those who experience multi-irAEs usually had significantly higher LDH (p = 0.02) and myoglobin levels (p = 0.02) than those who did not experience them. All patients were treated with steroids timely, and the mortality rate was 5.6% in our study. In this study, we explored risk factors for severe myocarditis and emphasized the importance of a multidisciplinary team in assisting diagnosis and treatment options. It is critical to initiate corticosteroid therapy, regardless of the severity of the myocarditis. |
format | Online Article Text |
id | pubmed-9294234 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92942342022-07-20 Intrinsic Differences in Immune Checkpoint Inhibitor-Induced Myocarditis: A Retrospective Analysis of Real World Data Lei, Yanna Zheng, Xiufeng Huang, Qian Li, Xiaoying Qiu, Meng Liu, Ming Front Pharmacol Pharmacology Immune-related myocarditis is a severe and even life-threatening immune-related adverse event (irAE) which may also be underestimated due to the challenge in diagnosis. The inherent difference between individuals with immune-associated myocarditis has received little attention. Our study aimed to identify which baseline characteristics could contribute to distinguishing mild from severe ICI myocarditis. A retrospective analysis was conducted between March 2019 and June 2020 in West China Hospital, and 18 patients with immune-related myocarditis were studied. Patients were classified as having mild (n = 12) or severe myocarditis (n = 6), according to the clinical manifestations and hemodynamic complications. Factors associated with severe myocarditis were identified by comparing covariates derived from medical records in various groups. In this retrospective analysis, the median age of the 18 patients was 60 years old. Most myocarditis cases occur early and approximately after the first or second ICI infusion. The severity of myocarditis may be correlated with lactate dehydrogenase (LDH) (p = 0.04) and troponin levels (p = 0.0057). The relationship between troponin and myocarditis was further confirmed in another cohort, which included 30 patients. In addition, patients are more likely to develop multi-irAEs, and myositis was the most common second irAE. Those who experience multi-irAEs usually had significantly higher LDH (p = 0.02) and myoglobin levels (p = 0.02) than those who did not experience them. All patients were treated with steroids timely, and the mortality rate was 5.6% in our study. In this study, we explored risk factors for severe myocarditis and emphasized the importance of a multidisciplinary team in assisting diagnosis and treatment options. It is critical to initiate corticosteroid therapy, regardless of the severity of the myocarditis. Frontiers Media S.A. 2022-07-05 /pmc/articles/PMC9294234/ /pubmed/35865949 http://dx.doi.org/10.3389/fphar.2022.914928 Text en Copyright © 2022 Lei, Zheng, Huang, Li, Qiu and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Lei, Yanna Zheng, Xiufeng Huang, Qian Li, Xiaoying Qiu, Meng Liu, Ming Intrinsic Differences in Immune Checkpoint Inhibitor-Induced Myocarditis: A Retrospective Analysis of Real World Data |
title | Intrinsic Differences in Immune Checkpoint Inhibitor-Induced Myocarditis: A Retrospective Analysis of Real World Data |
title_full | Intrinsic Differences in Immune Checkpoint Inhibitor-Induced Myocarditis: A Retrospective Analysis of Real World Data |
title_fullStr | Intrinsic Differences in Immune Checkpoint Inhibitor-Induced Myocarditis: A Retrospective Analysis of Real World Data |
title_full_unstemmed | Intrinsic Differences in Immune Checkpoint Inhibitor-Induced Myocarditis: A Retrospective Analysis of Real World Data |
title_short | Intrinsic Differences in Immune Checkpoint Inhibitor-Induced Myocarditis: A Retrospective Analysis of Real World Data |
title_sort | intrinsic differences in immune checkpoint inhibitor-induced myocarditis: a retrospective analysis of real world data |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294234/ https://www.ncbi.nlm.nih.gov/pubmed/35865949 http://dx.doi.org/10.3389/fphar.2022.914928 |
work_keys_str_mv | AT leiyanna intrinsicdifferencesinimmunecheckpointinhibitorinducedmyocarditisaretrospectiveanalysisofrealworlddata AT zhengxiufeng intrinsicdifferencesinimmunecheckpointinhibitorinducedmyocarditisaretrospectiveanalysisofrealworlddata AT huangqian intrinsicdifferencesinimmunecheckpointinhibitorinducedmyocarditisaretrospectiveanalysisofrealworlddata AT lixiaoying intrinsicdifferencesinimmunecheckpointinhibitorinducedmyocarditisaretrospectiveanalysisofrealworlddata AT qiumeng intrinsicdifferencesinimmunecheckpointinhibitorinducedmyocarditisaretrospectiveanalysisofrealworlddata AT liuming intrinsicdifferencesinimmunecheckpointinhibitorinducedmyocarditisaretrospectiveanalysisofrealworlddata |